Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Contributors
Akira Shizuo, Juan Anguíta, Gregory M. Anstead, Cynthia Aranow, Howard A. Austin, Subash Babu, James R. Baker, Christopher Baliga, Mark Ballow, James E. Balow, Emil J. Bardana, Matthias Becker, John W. Belmont, Dina Ben‐Yehuda, Claudia Berek, Thomas Bieber, J. W. J. Bijlsma, Jack Bleesing, Sarah E. Blutt, Elena Borzova, Prosper N. Boyaka, Knut Brockow, Ralph C. Budd, Frank Buttgereit, Virginia L. Calder, Fabio Candotti, Sebastian Carotta, Jean‐Laurent Casanova, Marília Cascalho, Edwin S. L. Chan, Javier Chinen, Monique E. Cho, Lisa Christopher-Stine, Helen Collins, Andrew P. Cope, Irene Cortese, Bruce N. Cronstein, Adnan Ćustović, Marinos C. Dalakas, Blythe H. Devlin, Betty Diamond, Angela Dispenzieri, Joost P.H. Drenth, Terry W. Du Clos, Mark S. Dykewicz, Todd N. Eagar, George S. Eisenbarth, Charles O. Elson, Doruk Erkan, Mark E. Feinberg, Erol Fikrig, Alain Fischer, Thomas A. Fleisher, Andrew P. Fontenot, Karen A. Fortner, Anthony J. Frew, Thea M. Friedman, Kohtaro Fujihashi, Stephen J. Galli, Moshe E. Gatt, M. Eric Gershwin, Jörg J. Goronzy, Clive Grattan, Neil S. Greenspan, Beatrix Grubeck-Loebenstein, Gabrielle Haeberli, Russell P. Hall, Robert Hamilton, Gregory R. Harriman, Khaled Hassan, Arthur Helbling, David B. Hellmann, Vivian Hernandez‐Trujillo, Melanie Hingorani, Steven M. Holland, Henry A. Homburger, McDonald K. Horne, Gabor G. Illei, John B. Imboden, Ken J. Ishii, Shai Izraeli, Elaine S. Jaffe, Sirpa Jalkanen, Carl H. June, Barry D. Kahan, Axel Kallies, Stefan H. E. Kaufmann, Arthur F. Kavanaugh, Gary A. Koretzky, Robert Korngold, Rania D. Kovaiou, Douglas B. Kuhns, Roger Kurlander, Robert A. Kyle, H. Clifford Lane, Arian Laurence, Françoise Le Deist, Susan J. Lee, Steven J. Lemery, Michael J. Lenardo (2008). ContributorsContributors. Elsevier eBooks, pp. xiii-xxx, DOI: 10.1016/b978-0-323-04404-2.10102-2,
Chapter in a book384 days agoVenetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study
Rakesh Popat, Meral Beksaç, Meletios A Dimopoulos, Moshe E. Gatt, Francesca Gay, Jae‐Cheol Jo, Prashant Kapoor, Eirini Katodritou, K. Martin Kortüm, Silvia Ling, Chandramouli Nagarajan, Kenshi Suzuki, Lugui Qiu, Maika Onishi, Grace Ku, Monique Dail, Nabanita Mukherjee, Jeremy A. Ross, Mohamed Badawi, Mary Jean Fusco, Edyta Dobkowska, Emma Arriola, Orlando F. Bueno, Nizar J. Bahlis, Shinsuke Iida, Philippe Moreau, Jason Valent, María‐Victoria Mateos (2025). Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study. , 44(3), DOI: https://doi.org/10.1200/jco-25-00924.
Article43 days agoBelantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial
Vânia Hungria, Paweł Robak, Marek Hus, Vera Zherebtsova, Christopher Wård, P. Joy Ho, Roman Hájek, Kihyun Kım, Sebastian Grosicki, Hanlon Sia, Adam Bryant, Marcelo Pitombeira de Lacerda, Gracia Martínez, Anna Sureda Balarí, Irwindeep Sandhu, Claudio Cerchione, Peter Ganly, Meletios A Dimopoulos, Chengcheng Fu, Mamta Garg, Al-Ola Abdallah, Moshe E. Gatt, Albert Oriol Rocafiguera, Michèle Cavo, Robert M. Rifkin, Tomoaki Fujisaki, Michał Mielnik, Joseph Ficek, Alejandro Mantero, Nick Pirooz, Sybil Varghese, Shing Yip Lee, Astrid McKeown, Rachel Rogers, Hena Baig, Lydia Eccersley, Sumita Roy–Ghanta, Pralay Mukhopadhyay, Jacqueline Nielsen, Joanna Opalińska, María-Victoria Mateos (2025). Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial. , 26(8), DOI: https://doi.org/10.1016/s1470-2045(25)00330-4.
Article43 days agoA phase 2 randomized study of modakafusp alfa as a single agent for patients with relapsed/refractory multiple myeloma
Sarah A. Holstein, Shebli Atrash, Hira Mian, Meletios A Dimopoulos, Fredrik Schjesvold, Rakesh Popat, Nishi Shah, Moshe E. Gatt, Christian B. Gocke, Laurent Frenzel, Cyrille Touzeau, Meral Beksaç, Salomon Manier, Hila Magen, Patrick M. Travis, Omar Nadeem, Kaveri Suryanarayan, Cheryl Li, Shuli Li, Allison Nelson, Dasha Cherepanov, Xavier Parot, Dan T. Vogl (2025). A phase 2 randomized study of modakafusp alfa as a single agent for patients with relapsed/refractory multiple myeloma. , 146(9), DOI: https://doi.org/10.1182/blood.2024027873.
Article43 days agoEfficacy of venetoclax-dexamethasone (VenDex) v pomalidomide-dexamethasone (PomDex) in patients (Pts) with t(11;14)-positive relapsed/refractory multiple myeloma [t(11;14)+ RRMM]: Phase 3 CANOVA study biomarker subgroup analysis.
Nizar J. Bahlis, Rakesh Popat, Meral Beksaç, Meletios A Dimopoulos, Moshe E. Gatt, Francesca Gay, Jae‐Cheol Jo, Prashant Kapoor, K. Martin Kortüm, Silvia Ling, Chandramouli Nagarajan, Kenshi Suzuki, Maika Onishi, Monique Dail, Emily L. Rossi, Xizhi Luo, Emma Arriola, Orlando F. Bueno, Jeremy A. Ross, María‐Victoria Mateos (2024). Efficacy of venetoclax-dexamethasone (VenDex) v pomalidomide-dexamethasone (PomDex) in patients (Pts) with t(11;14)-positive relapsed/refractory multiple myeloma [t(11;14)+ RRMM]: Phase 3 CANOVA study biomarker subgroup analysis.. , 42(16_suppl), DOI: https://doi.org/10.1200/jco.2024.42.16_suppl.7510.
Article43 days ago